BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 33795496)

  • 1. Disease phenotype and diagnostic delay in Saudi patients with primary Sjögren's syndrome: An exploratory cross-sectional study.
    Omair MA; AlQahtani BS; AlHamad EH; Tashkandy YA; Othman NS; AlShahrani KA; Paramasivam MP; AlEnzi F; Halwani R; Daghestani MH
    Saudi Med J; 2021 Apr; 42(4):405-410. PubMed ID: 33795496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defining disease activity states and clinically meaningful improvement in primary Sjögren's syndrome with EULAR primary Sjögren's syndrome disease activity (ESSDAI) and patient-reported indexes (ESSPRI).
    Seror R; Bootsma H; Saraux A; Bowman SJ; Theander E; Brun JG; Baron G; Le Guern V; Devauchelle-Pensec V; Ramos-Casals M; Valim V; Dörner T; Tzioufas A; Gottenberg JE; Solans Laqué R; Mandl T; Hachulla E; Sivils KL; Ng WF; Fauchais AL; Bombardieri S; Priori R; Bartoloni E; Goeb V; Praprotnik S; Sumida T; Nishiyama S; Caporali R; Kruize AA; Vollenweider C; Ravaud P; Meiners P; Brito-Zerón P; Vitali C; Mariette X;
    Ann Rheum Dis; 2016 Feb; 75(2):382-9. PubMed ID: 25480887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. European League Against Rheumatism Sjögren's Syndrome Disease Activity Index and European League Against Rheumatism Sjögren's Syndrome Patient-Reported Index: a complete picture of primary Sjögren's syndrome patients.
    Seror R; Gottenberg JE; Devauchelle-Pensec V; Dubost JJ; Le Guern V; Hayem G; Fauchais AL; Goeb V; Hachulla E; Hatron PY; Larroche C; Morel J; Pedriger A; Puechal X; Rist S; Saraux A; Sene D; Sibilia J; Vittecoq O; Zarnitsky C; Labetoulle M; Ravaud P; Mariette X
    Arthritis Care Res (Hoboken); 2013 Aug; 65(8):1358-64. PubMed ID: 23436737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associated factors with interstitial lung disease and health-related quality of life in Chinese patients with primary Sjögren's syndrome.
    Zhao R; Wang Y; Zhou W; Guo J; He M; Li P; Gao J; Gu Z; Dong C
    Clin Rheumatol; 2020 Feb; 39(2):483-489. PubMed ID: 31578648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of systemic activity of pediatric primary Sjögren's syndrome by EULAR Sjögren's syndrome disease activity index (ESSDAI).
    Kobayashi I; Okura Y; Ueki M; Tozawa Y; Takezaki S; Yamada M; Ariga T
    Mod Rheumatol; 2019 Jan; 29(1):130-133. PubMed ID: 29529894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disease activity and damage in patients with primary Sjogren's syndrome: Prognostic value of salivary gland ultrasonography.
    Milic V; Colic J; Cirkovic A; Stanojlovic S; Damjanov N
    PLoS One; 2019; 14(12):e0226498. PubMed ID: 31891590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of sleep quality on clinical features of primary Sjögren's syndrome.
    Chung SW; Hur J; Ha YJ; Kang EH; Hyon JY; Lee HJ; Song YW; Lee YJ
    Korean J Intern Med; 2019 Sep; 34(5):1154-1164. PubMed ID: 29458245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glandular involvement in primary Sjögren's syndrome patients with interstitial lung disease-onset and sicca-onset, a single centre cross-sectional study.
    La Rocca G; Ferro F; Bulleri A; Fulvio G; Fonzetti S; Donati V; Romei C; Mosca M; Baldini C
    Clin Exp Rheumatol; 2022 Dec; 40(12):2344-2349. PubMed ID: 36533977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe intestinal dysbiosis is prevalent in primary Sjögren's syndrome and is associated with systemic disease activity.
    Mandl T; Marsal J; Olsson P; Ohlsson B; Andréasson K
    Arthritis Res Ther; 2017 Oct; 19(1):237. PubMed ID: 29065905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of EULAR primary Sjögren's syndrome disease activity (ESSDAI) and patient indexes (ESSPRI).
    Seror R; Theander E; Brun JG; Ramos-Casals M; Valim V; Dörner T; Bootsma H; Tzioufas A; Solans-Laqué R; Mandl T; Gottenberg JE; Hachulla E; Sivils KL; Ng WF; Fauchais AL; Bombardieri S; Valesini G; Bartoloni E; Saraux A; Tomsic M; Sumida T; Nishiyama S; Caporali R; Kruize AA; Vollenweider C; Ravaud P; Vitali C; Mariette X; Bowman SJ;
    Ann Rheum Dis; 2015 May; 74(5):859-66. PubMed ID: 24442883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of orexin in fatigue and sleep quality in patients with primary Sjögren's syndrome.
    Sandikci SC; Gultuna S; Ozisler C; Aydin FN
    Z Rheumatol; 2024 Feb; 83(Suppl 1):242-247. PubMed ID: 38108866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations of cigarette smoking with disease phenotype and type I interferon expression in primary Sjögren's syndrome.
    Olsson P; Bodewes ILA; Nilsson AM; Turesson C; Jacobsson LTH; Theander E; Versnel MA; Mandl T
    Rheumatol Int; 2019 Sep; 39(9):1575-1584. PubMed ID: 31139950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Inflammatory Cytokine Levels with Extra Glandular Manifestations, Fatigue, and Disease Activity in Primary Sjögren's Syndrome in Saudi Patients: A Cross-Sectional Study.
    Alqahtani B; Daghestani M; Omair MA; Alhamad EH; Tashkandy Y; Othman N; Al Shahrani K; Paramasivam MP; Alenzi F; Halwani R; Alkhulaifi FM; Alomar SY
    Diagnostics (Basel); 2023 Sep; 13(19):. PubMed ID: 37835779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Responsiveness of disease activity indices ESSPRI and ESSDAI in patients with primary Sjögren's syndrome treated with rituximab.
    Meiners PM; Arends S; Brouwer E; Spijkervet FK; Vissink A; Bootsma H
    Ann Rheum Dis; 2012 Aug; 71(8):1297-302. PubMed ID: 22258489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elastographic ultrasound: an additional image tool in Sjögren's syndrome.
    Kimura-Hayama E; Criales-Vera S; Azpeitia-Espinosa L; Pacheco-Molina C; Reyes E; Lima G; Hernandez-Ramirez D; Llorente L; Hernandez-Molina G
    Int J Rheum Dis; 2018 Jun; 21(6):1293-1300. PubMed ID: 29624878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fatigue in Saudi Patients with Primary Sjögren's Syndrome and Its Correlation with Disease Characteristics and Outcome Measures: A Cross-Sectional Study.
    AlEnzi F; Alqahtani B; Alhamad EH; Daghestani M; Tashkandy Y; Othman N; Alshahrani K; Paramasivam MP; Halwani R; Omair MA
    Open Access Rheumatol; 2020; 12():303-308. PubMed ID: 33293878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome measures for primary Sjögren's syndrome: a comprehensive review.
    Seror R; Theander E; Bootsma H; Bowman SJ; Tzioufas A; Gottenberg JE; Ramos-Casals M; Dörner T; Ravaud P; Mariette X; Vitali C
    J Autoimmun; 2014 Jun; 51():51-6. PubMed ID: 24411404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Sjögren's Syndrome: Epidemiological, Diagnostic, Therapeutic and Evolutionary Aspects in the Aristide-Le-Dantec Teaching Hospital of Dakar, Senegal (2012-2016)].
    Salissou GM; Moustapha N; Kaba C; Coumba D; Saïdou D
    Bull Soc Pathol Exot; 2020; 113(3):136-142. PubMed ID: 33825393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do the EULAR Sjögren's syndrome outcome measures correlate with health status in primary Sjögren's syndrome?
    Lendrem D; Mitchell S; McMeekin P; Gompels L; Hackett K; Bowman S; Price E; Pease CT; Emery P; Andrews J; Lanyon P; Hunter J; Gupta M; Bombardieri M; Sutcliffe N; Pitzalis C; McLaren J; Cooper A; Regan M; Giles I; Isenberg D; Saravanan V; Coady D; Dasgupta B; McHugh N; Young-Min S; Moots R; Gendi N; Akil M; Griffiths B; Ng WF;
    Rheumatology (Oxford); 2015 Apr; 54(4):655-9. PubMed ID: 25240612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated levels of faecal calprotectin in primary Sjögren's syndrome is common and associated with concomitant organic gastrointestinal disease.
    Andréasson K; Ohlsson B; Mandl T
    Arthritis Res Ther; 2016 Jan; 18():9. PubMed ID: 26759247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.